Evolva shareholders approve all Board proposals in AGM: Green light for Abunda acquisition
The Annual General Meeting of Evolva Holding SA has approved all proposals put forward by the Board of Directors, including those regarding the Company’s intended acquisition of its R&D partner Abunda Nutrition, Inc.
A total of 85 shareholders were present at the meeting which took place in Basel today. 100,379,115 shares were represented, or 71.9% of the total number of shares issued (139,665,164). A detailed overview of the agenda items and the proposals is available on the Evolva website.
The AGM proposals included increases in conditional and authorised capital in Evolva’s Articles of Association. The shareholders’ approval of these items clears the way for the closing of Evolva’s acquisition of Abunda Nutrition, Inc. This transaction is expected to take place around the end of June 2011.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Aragen Bioscience, Inc. and CEVEC Sign License Agreement for Human CAP and CAP-T Technology
